Medical Devices Investors & VC Firms in United States
1104 firms in this list, with a median first check of $500K. 275 of them lead rounds. Generated from verified public data and updated continuously.
Elm Street Ventures
New HavenSeed–Series A$250K – $1M
15 people
SpringTide Ventures
BostonPre-Seed–Series A$500K – $5M
15 people
Suncoast Ventures
San FranciscoPre-Seed–Series A$50K
16 people
Unorthodox Ventures
AustinSeed–Growth$1M – $5M
16 people
Delos Capital
CambridgePre-Seed–Growth
15 people
MassVentures
WalthamPre-Seed–Seed$250K – $500K
9 people
HealthQuest Capital
Redwood CityGrowth–Late Stage
14 people
Taihill Venture
BostonPre-Seed–Seed
11 people
Qiming Venture Partners USA
CambridgeSeed–Series B
19 people
Plum Alley Investments
New YorkSeed–Series A$500K – $1.5M
15 people
Varsity Healthcare Partners
Los Angeles
20 people
JobsOhio Ventures
ColumbusPre-Seed–Series A
4 people
Gore Range Capital
New YorkSeries A–Late Stage$500K – $5M
17 people
Omega Funds
BostonSeed–Late Stage
19 people
QuestMark Partners
BaltimoreGrowth$5M – $15M
7 people
Westlake Village BioPartners
Los AngelesPre-Seed–Series A$100K – $5M
13 people
Alix Ventures
San FranciscoSeed–Series A$100K – $500K
18 people
Alpha Square Group
New YorkSeries A–Series B
14 people
Necessary Ventures
San FranciscoPre-Seed–Seed$1M – $2M
11 people
Agility Capital
Santa BarbaraGrowth
4 people
Altaris Capital Partners
New York
22 people
Next Ventures
AustinSeed–Series A$500K – $3M
9 people
Delaware Crossing Investor Group
PhiladelphiaSeed–Series A
5 people
Taiwan Global Angels
BerkeleyPre-Seed–Growth$300K – $3M
19 people
Related lists
Investors & VC Firms in North America (13286)Investors & VC Firms in United States (12284)Investors & VC Firms in Europe (6052)AI & Machine Learning Investors & VC Firms (5303)Investors & VC Firms in Global (5278)Fintech Investors & VC Firms (5112)Healthtech Investors & VC Firms (4639)SaaS Investors & VC Firms (4498)Enterprise Software Investors & VC Firms (4394)Crypto & Web3 Investors & VC Firms (4130)
Data sourced from public filings and firms' own websites — see our methodology.





































































































